Journal List > J Cardiovasc Imaging > v.26(2) > 1097091

Kim, Heo, Shin, Lim, and Park: E/E′ and D-shaped Left Ventricle Severity in Patients with Increased Pulmonary Artery Pressure

Abstract

BACKGROUND

D-shaped left ventricle (D-LV) is an interesting echocardiographic finding in pulmonary hypertension (PH) and is the result of structural distortion of the interventricular septum. The eccentricity index (EI) is a quantitative measure used to evaluate the severity of D-LV in patients with increased pulmonary artery pressure (PAP). However, D-LV and EIs have rarely been studied in terms of their association with hemodynamic factors.

METHODS

A total of 526 patients with a maximal tricuspid regurgitation velocity (VmaxTR) > 2.8 m/s on echocardiography identified between January 2012 and December 2017 were enrolled. After exclusion, a total of 289 patients were analyzed. The association between D-LV and hemodynamic factors were analyzed using logistic regression. Furthermore, factors that impacted the severity of the D-LV, as defined by EIs, were also analyzed using the multiple linear regression model.

RESULTS

In the multivariate logistic regression model, higher pulmonary artery pressure (PAP, p = 0.001), lower tricuspid annular plane systolic excursion (TAPSE, p = 0.048), and E/E′ (p = 0.017) were found to be significant risk factors for the presence of D-LV. Additional analysis with age and body mass index added to independent variables, PAP (p = 0.008), TAPSE (p = 0.028), and age (p < 0.001) were significant risk factors for the presence of D-LV. In patients with D-LV, only E/E′ was independently associated with EIs (R2 = 0.666, p < 0.001).

CONCLUSIONS

In patients with increased PAP, D-LV is associated with PAP, TAPSE, E/E′, and age. EIs are associated with left ventricular filling pressure, represented as E/E′.

INTRODUCTION

Pulmonary hypertension (PH) is a hemodynamic and pathophysiologic condition, defined as an increase in pulmonary artery pressure (PAP) that results in right ventricular (RV) pressure overload and, ultimately, right heart failure and death.1)
Transthoracic echocardiography provides direct and indirect signs of elevated PAP and can be used as an excellent noninvasive screening test for patients with symptoms or risk factors for PH.1)2)
D-shaped left ventricle (D-LV), is an interesting echocardiographic finding in PH and is the result of structural distortion of the interventricular septum caused by an abnormal pressure gradient between the left and right ventricles. Although the presence of a D-LV is not a diagnostic feature of RV overload, this finding should prompt further investigation of the etiology and severity of right-sided pressure and volume overload.3)
The eccentricity index (EI) is a previously described quantitative measure that is used to evaluate septal flattening in patients with PH. The EI is a ratio of the left ventricular (LV) anteroposterior dimension to the septolateral dimension in the parasternal short-axis window. An index greater than 1.0 is abnormal and suggests RV overload.3)4)
The relationship between D-LV and hemodynamic factors such as RV systolic pressure (RVSP) or LV filling pressure, represented by E/E′, and other echocardiographic indices has not been clearly determined. These factors are important in clinical decision making, therefore, we investigated the echocardiographic parameters related to D-LV and the relationship between EIs and echocardiographic parameters in patients with increased PAP.

METHODS

Study population

We retrospectively analyzed a total of 526 patients with a maximal tricuspid regurgitation velocity (VmaxTR) > 2.8 m/s on echocardiography who were hospitalized at Hanyang University Medical Center between January 2012 and December 2017. For patients with multiple echocardiographic data, only the data initially obtained during the study period was used.
Because of the complex nature of PH, exclusion criteria were applied to homogenize the hemodynamic characteristics of PH, such as severe valve disease or valve replacement status, congenital heart disease, atrial fibrillation or sick sinus syndrome, tachycardia > 120 bpm, large pericardial effusion, leukemia or other cancer, acute shock state, heart failure with reduced ejection fraction of ischemic or non-ischemic origin, stage 4 or 5 chronic kidney disease, severe kyphoscoliosis, and poor windows (n = 237).

Data collection

Demographic and clinical data were collected, including age, sex, body mass index (BMI), blood pressure (BP), and cardiovascular risk factors. Laboratory data, including hemoglobin, B-type natriuretic peptide, and troponin-I levels and estimated glomerular filtration rate were also collected.
Routine echocardiographic examination using a standard commercial echocardiography machine (iE33, Philips) was performed. Echocardiographic parameters, including LV dimension, transmitral flow, E/E′, pulmonary outflow acceleration time, VmaxTR, right atrial pressure (RAP) defined by inferior vena cava size and collapsibility,1) RVSP defined as 4 × VmaxTR2 + RAP, and tricuspid annular plane systolic excursion (TAPSE) were obtained. Heart rate (HR) during echocardiography was recorded. LV posterior wall thickness (LVPWT) and interventricular septal thickness (IVST) were measured in end-diastole. End-diastole was defined as the frame in which LV volume is the largest.
Visual assessment confirmed the presence of a D-LV was analyzed in the standard parasternal short-axis view at the level of mid-papillary muscles in end-systole. The EI was obtained from the same frame images. End-systole was defined as the frame in which the smallest short-axis area was obtained. Measurements were performed by a single echocardiography physician.

Statistical analyses

Continuous variables were reported as the mean values with standard deviations and categorical variables were presented as the numbers and percentages. The t-test was used to compare continuous variables between groups, and the chi-squared test was used for categorical variables.
A multivariable logistic regression analysis was performed to evaluate factors that were associated with D-LV in patients with increased PAP that were assessed by echocardiography. Independent variables included HR, PAP, TAPSE, RVSP/systolic BP, LVPWT, and E/E′ in Model 1. The same independent variables along with age and BMI were used in Model 2. For patients with D-LV, factors related to the severity of D-LV defined by EIs were explored by multiple linear regression analysis with the same independent variables.
For all assessments, a p-value < 0.05 indicated a statistically significant result. Statistical analysis was performed using PASW 18.0 (SPSS, Chicago, IL, USA).

RESULTS

Baseline characteristics

A total of 289 patients (male, 34.9%; mean age, 67.4 years) were analyzed, and their characteristics according to presence or absence of D-LV are shown in Table 1. There were 80 patients (27.7%) with D-LV. Patients with D-LV were younger and had a significantly lower systolic BP and faster HR. They had a higher incidence of connective tissue disease, chronic obstructive lung disease, pulmonary thromboembolism (PTE), and heart failure with preserved ejection fraction. While the frequencies of hypertension, diabetes mellitus, coronary artery disease, and cerebrovascular disease were lower compared to those without D-LV, the hemoglobin and B-type natriuretic peptide levels were significantly higher in the D-LV group.
Table 1

Baseline clinical characteristics

jcvi-26-85-i001
Total (n = 289) D-LV (+) (n = 80) D-LV (−) (n = 209) p-value
Age (years) 67.4 ± 16.7 54.7 ± 18.8 72.3 ± 18.8 < 0.001
Male 101 (34.9) 23 (28.8) 78 (37.3) 0.215
BMI (kg/m2) 22.6 ± 3.9 21.9 ± 3.8 22.8 ± 3.9 0.109
Systolic BP (mmHg) 120 ± 17 116 ± 17 122 ± 17 0.014
Diastolic BP (mmHg) 72 ± 10 71 ± 11 72 ± 10 0.528
HR (bpm) 82 ± 20 93 ± 17 78 ± 19 < 0.001
Hypertension 165 (57.1) 28 (35.0) 137 (65.6) < 0.001
Diabetes mellitus 81 (28.0) 12 (15.0) 69 (33.0) 0.002
Connective tissue disease 53 (18.3) 34 (42.5) 19 (9.1) < 0.001
Coronary artery disease 42 (14.5) 6 (7.5) 36 (17.2) 0.036
Cerebrovascular disease 49 (17.0) 6 (7.5) 43 (20.6) 0.008
Chronic obstructive lung disease 29 (10.0) 13 (16.3) 16 (7.7) < 0.001
Pulmonary thromboembolism 33 (11.4) 18 (22.5) 15 (7.2) 0.001
HFpEF 90 (31.1) 17 (21.3) 73 (34.9) 0.033
Hemoglobin (g/dL) 11.6 ± 2.2 12.3 ± 2.4 11.4 ± 2.1 0.002
BNP (pg/mL) 461 ± 595 634 ± 670 386 ± 546 0.006
Troponin-I (ng/mL) 0.16 ± 0.43 0.14 ± 0.45 0.17 ± 0.41 0.647
eGFR (mL/min/1.73 m3) 82.6 ± 29.8 86.1 ± 31.9 81.2 ± 28.8 0.217
The data are presented as the mean ± SD or n (%).
BMI: body mass index, BNP: brain natriuretic peptide, BP: blood pressure, D-LV: D-shaped left ventricle, eGFR: estimated glomerular filtration rate, HFpEF: heart failure with preserved ejection fraction, HR: heart rate.

Echocardiographic parameters

There were no significant differences in ejection fraction, maximal transaortic velocity, IVST, aortic root diameter in M-mode, E/A ratio, deceleration time, or mitral annular velocity between groups. However, EI, VmaxTR, inferior vena cava plethora, PAP, and RVSP/systolic BP were higher, and TAPSE, pulmonary outflow acceleration time, left ventricular end-diastolic dimension, left ventricular end-systolic dimension, LVPWT, left atrial diameter in M-mode, peak early diastolic mitral filling (E) velocity, peak late diastolic mitral filling (A) velocity, and the E/E′ ratio were lower in the D-LV group (Table 2).
Table 2

Echocardiographic parameters

jcvi-26-85-i002
Total (n = 289) D-LV (+) (n = 80) D-LV (−) (n = 209) p-value
Eccentricity index 1.13 ± 0.24 1.38 ± 0.17 1.03 ± 0.19 < 0.001
Ejection fraction (%) 63 ± 7 63 ± 8 63 ± 7 0.862
VmaxTR (m/s2) 3.36 ± 0.46 3.85 ± 0.55 3.18 ± 0.23 < 0.001
TAPSE (mm) 17.8 ± 4.8 15.9 ± 4.4 18.6 ± 4.8 < 0.001
PVaccT (ms) 106 ± 22 93 ± 21 114 ± 19 < 0.001
IVC plethora 47 (18.4) 16 (34.8) 31 (14.8) 0.003
VmaxAV (m/s2) 2.20 ± 0.83 2.39 ± 1.95 2.17 ± 0.70 0.674
PAP (mmHg) 54.9 ± 13.4 73.7 ± 19.7 50.8 ± 6.3 < 0.001
RVSP/SBP (%) 45.9 ± 12.6 61.9 ± 17.2 42.5 ± 7.9 < 0.001
LVEDD (mm) 4.55 ± 0.60 4.10 ± 0.61 4.72 ± 0.50 < 0.001
LVESD (mm) 2.99 ± 0.49 2.70 ± 0.49 3.10 ± 0.44 < 0.001
IVST (mm) 0.91 ± 0.15 0.89 ± 0.16 0.92 ± 0.14 0.091
LVPWT (mm) 0.86 ± 0.13 0.83 ± 0.14 0.88 ± 0.12 0.003
Ao diameter (cm) 3.30 ± 0.37 3.24 ± 0.44 3.32 ± 0.34 0.102
LA diameter (cm) 3.57 ± 0.76 3.15 ± 0.64 3.73 ± 0.74 < 0.001
AV cusp separation (cm) 1.71 ± 0.18 1.75 ± 0.19 1.70 ± 0.18 0.16
E velocity (m/s) 0.79 ± 0.24 0.65 ± 0.17 0.85 ± 0.24 < 0.001
A velocity (m/s) 0.82 ± 0.23 0.74 ± 0.23 0.86 ± 0.20 < 0.001
DT (ms) 193 ± 41 189 ± 46 196 ± 38 0.258
IVRT (ms) 78 ± 10 80 ± 11 77 ± 9 0.027
E′ velocity (m/s) 0.07 ± 0.02 0.06 ± 0.02 0.07 ± 0.02 0.071
E/E′ 12.4 ± 4.0 10.8 ± 3.3 12.9 ± 4.1 < 0.001
E/A 0.96 ± 0.34 0.93 ± 0.32 0.97 ± 0.35 0.406
The data are presented as the mean ± SD or n (%).
A: peak late diastolic mitral filling, Ao: aortic root, AV: aortic valve, D-LV: D-shaped left ventricle, DT: deceleration time, E: peak early diastolic mitral filling, E′: mitral annular, IVC: inferior vena cava, IVRT: isovolumetric relaxation time, IVST: end-diastolic interventricular septal thickness, LA: left atrium, LVEDD: left ventricular end-diastolic dimension, LVESD: left ventricular end-systolic dimension, LVPWT: end-diastolic left ventricle posterior wall thickness, PAP: pulmonary arterial pressure, PVaccT: acceleration time of pulmonary outflow, RVSP: right ventricular systolic pressure, SBP: systolic blood pressure, TAPSE: tricuspid annular plane systolic excursion, VmaxAV: maximal transaortic velocity, VmaxTR: maximal velocity of tricuspid regurgitation.

D-LV associated factors

Univariate logistic regression analysis showed that the presence of D-LV was associated with HR, PAP, TAPSE, RVSP/systolic BP, LVPWT, E/E′, and age. Multivariate logistic regression analysis showed that PAP (odds ratio [OR], 1.135; 95% confidence interval [CI], 1.051–1.226; p = 0.001), TAPSE (OR, 0.909; 95% CI, 0.827–0.999; p = 0.048), and E/E′ (OR: 0.847; 95% CI: 0.739–0.970, p = 0.017) were significant factors for the presence of D-LV in Model 1. In Model 2, PAP (OR, 1.131; 95% CI, 1.032–1.239; p = 0.008), TAPSE (OR, 0.893; 95% CI, 0.807–0.988; p = 0.028), and age (OR, 0.942; 95% CI, 0.912–0.974; p < 0.001) were significant factors for the presence of D-LV (Table 3).
Table 3

Multivariable logistic regression analysis for factors associated with D-shaped left ventricle

jcvi-26-85-i003
Independent variables Univariate Model 1* Model 2
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
HR (bpm) 1.046 (1.029–1.062) < 0.001 1.015 (0.991–1.039) 0.228 1.027 (0.999–1.056) 0.057
PAP (mmHg) 1.166 (1.115–1.219) < 0.001 1.135 (1.051–1.226) 0.001 1.131 (1.032–1.239) 0.008
TAPSE (mm) 0.875 (0.822–0.931) < 0.001 0.909 (0.827–0.999) 0.048 0.893 (0.807–0.988) 0.028
RVSP/SBP (%) 1.142 (1.098–1.188) < 0.001 1.014 (0.947–1.087) 0.684 1.032 (0.949–1.122) 0.464
LVPWT (mm) 0.105 (0.023–0.469) 0.003 0.054 (0.001–3.003) 0.154 0.229 (0.003–20.051) 0.519
E/E′ 0.842 (0.774–0.917) < 0.001 0.847 (0.739–0.970) 0.017 0.875 (0.747–1.025) 0.099
Age (years) 0.936 (0.919–0.953) < 0.001 0.942 (0.912–0.974) < 0.001
BMI (kg/m2) 0.945 (0.882–1.013) 0.111 1.161 (0.979–1.377) 0.085
*Independent variables were HR, PAP, TAPSE, RVSP/SBP, LVPWT, and E/E′.
Independent variables were HR, PAP, TAPSE, RVSP/SBP, LVPWT, E/E′, age, and BMI.
BMI: body mass index, HR: heart rate, LVPWT: end-diastolic left ventricular posterior wall thickness, PAP: pulmonary arterial pressure, RVSP: right ventricular systolic pressure, SBP: systolic blood pressure, TAPSE: tricuspid annular plane systolic excursion.

D-LV and EIs correlations

Table 4 summarizes factors associated with EIs. Simple linear regression analysis showed that E/E′ (r = 0.793, R2 = 0.629, p < 0.001) and age (r = 0.243, R2 = 0.059, p = 0.030) were associated with EIs. According to the multivariable model, only E/E′ was independently associated with EIs (R2 = 0.666, p < 0.001; the regression equation, EIs = 1.848 – 0.044 * E/E′; Figure 1).
Table 4

Univariable and multivariable correlates of eccentricity index in patients with D-shaped left ventricle

jcvi-26-85-i004
Univariable model Multivariable model
r R2 p-value p-value
Model characteristics R2 = 0.666
HR (bpm) 0.027 0.001 0.81
PAP (mmHg) 0.058 0.003 0.704
TAPSE (mm) 0.017 < 0.001 0.88
RVSP/SBP 0.045 0.002 0.77
LVPWT (mm) 0.011 < 0.001 0.924
E/E′ 0.793 0.629 < 0.001 β = − 0.044 < 0.001
Age (years) 0.243 0.059 0.030
BMI (kg/m2) 0.079 0.006 0.487
BMI: body mass index, HR: heart rate, LVPWT: end-diastolic left ventricular posterior wall thickness, PAP: pulmonary arterial pressure, RVSP: right ventricular systolic pressure, SBP: systolic blood pressure, TAPSE: tricuspid annular plane systolic excursion.
Figure 1

Relationship between the eccentricity index (EI) and E/E′ in patients with D-shaped left ventricle.

jcvi-26-85-g001

DISCUSSION

Our data showed that PAP, TAPSE, E/E′, and age were associated with the presence of D-LV in patients with increased PAP that was assessed by echocardiography. Furthermore, for patients with D-LV, the only factor that related to the severity of D-LV, as defined by EIs, was E/E′. To the best of our knowledge, this is the first study that has investigated factors that are associated with the presence and severity of D-LV in patients with increased PAP that was assessed by echocardiography. Our findings suggest a possible link between E/E′ and D-LV severity in patients with increased PAP.
The EI is a simple measure of septal curvature that was first described by Ryan et al.5) The study showed that patients with RV pressure overload had systolic septal flattening, whereas patients with RV volume overload had diastolic septal flattening.5) There have been several previous studies on the determinants of the EIs. Jessup et al.6) demonstrated that the transseptal pressure gradient is a key determinant of abnormal septal motion and flattening in patients with PH. More recently, Haddad et al.7) reported a correlation between EIs and ventricular interdependence, and Watson et al.4) reported that EIs correlated well with RVSP/systolic BP. López-Candales8) reported that elevated systolic PAP was the best determinant of an abnormal septal curvature in chronic PH. Consistent with a previous study, we have also found that PAP was independently associated with D-LV. However, the interventricular pressure gradient was not significantly associated with D-LV on multivariable analysis, whereas E/E′ was strongly associated with EIs in patients who already presented with D-LV.
Previously, Mahmud et al.9) reported that E/A was consistently decreased in patients with chronic thromboembolic pulmonary hypertension and that E/A varies inversely with PAP. After pulmonary thromboendarterectomy, E/A and pulmonary capillary wedge pressure were significantly increased in conjunction with decreased PAP. The authors explained that impaired LV filling resulted in distortion of LV cavity geometry caused by RV pressure overload and leftward displacement of the interventricular septum.9) Our results were related to results of a previous study, which reported that factors associated with D-LV in PH were associated with increased PAP (RV pressure overload) and decreased E/E′ (decreased LV filling). However, it was shown that the severity of D-LV, defined as the EIs, was associated with E/E′ independently of PAP. Based on these results, D-LV might result from a combination of RV pressure overload and distortion of LV cavity geometry, which results in impairment of LV filling, and decreased LV filling aggravates D-LV severity.
Various factors may influence the presence and severity of D-LV. For example, excess weight on LV diastolic dysfunction10) and RV dysfunction11) have been documented. Moreover, obesity was associated with decreased functional capacity in patients with PH.12) As cardiac and pulmonary diseases increase with aging, the prevalence of PH also increases. Previous data have shown that, although PH was once thought to affect young adults, the mean age of patients with PH now represents a growing proportion of older patients.13) In our study population, there was no difference in BMI between groups, and patients with D-LV were younger than other patients. Although age and BMI may affect PAP, D-LV was not simply determined by PAP but may be determined by interactions between LV and RV hemodynamics.
A similar mechanism is found in the pathophysiology of PTE in that thromboembolism leads to increased pulmonary vascular resistance, resulting in RV pressure overload. Decreased RV output and displacement of the interventricular septum could limit diastolic LV filling.9)14) However, in our study, the association between EIs and E/E′ in patients with D-LV was unchanged when analyzed, except in patients with PTE. (R2 = 0.669, p < 0.001).
Another possible explanation for the correlation between decreased E/E′ and worsening of EIs is that the decreased LV filling pressure in patients with compromised LV cavity, as in hypertrophic cardiomyopathy, could worsen the severity in patients with existing D-LV. This finding could be applied to treatment plans from a clinical perspective, and additional confirmation is possible via repeated measurements in the same patients.
D-LV in echocardiography is a distinct finding of PH which needs to be understood for its hemodynamic interpretation. In our study, the most important factor for D-LV was E/E′, which indicates that the LV filling pressure is more important than the previously known factors, such as the severity of PH, i.e., RVSP or RVSP/systolic BP or TAPSE.
There were several limitations to our study. First, we did not perform cardiac catheterization to measure RVSP directly, which could decrease the accuracy of the study. Second, this study was conducted in a single center which could cause sampling bias. Third, there are not enough previous studies on EIs to limit the selection of confounding variables.
In conclusion, increased PAP, decreased TAPSE, E/E′, and age were found to be associated with the presence of D-LV in patients with increased PAP that were assessed by echocardiography. Moreover, for patients with D-LV, E/E′ was the only factor that was related to the severity of D-LV, as defined by the EIs.

Notes

Conflict of Interest The authors have no financial conflicts of interest.

References

1. Bossone E, D'Andrea A, D'Alto M, et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr. 2013; 26:1–14.
crossref
2. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37:67–119.
3. Karas MG, Kizer JR. Echocardiographic assessment of the right ventricle and associated hemodynamics. Prog Cardiovasc Dis. 2012; 55:144–160.
crossref
4. Watson T, McCracken CE, Slesnick T, Kanaan U, Border WL, Sachdeva R. Quantitative assessment of ventricular septal contour for estimation of right ventricular pressure. Echocardiography. 2016; 33:444–449. quiz 443.
crossref
5. Ryan T, Petrovic O, Dillon JC, Feigenbaum H, Conley MJ, Armstrong WF. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol. 1985; 5:918–927.
crossref
6. Jessup M, Sutton MS, Weber KT, Janicki JS. The effect of chronic pulmonary hypertension on left ventricular size, function, and interventricular septal motion. Am Heart J. 1987; 113:1114–1122.
crossref
7. Haddad F, Guihaire J, Skhiri M, et al. Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension. Echocardiography. 2014; 31:699–707.
crossref
8. López-Candales A. Determinants of an abnormal septal curvature in chronic pulmonary hypertension. Echocardiography. 2015; 32:49–55.
crossref
9. Mahmud E, Raisinghani A, Hassankhani A, et al. Correlation of left ventricular diastolic filling characteristics with right ventricular overload and pulmonary artery pressure in chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2002; 40:318–324.
crossref
10. Russo C, Jin Z, Homma S, et al. Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol. 2011; 57:1368–1374.
11. Wong CY, O'Moore-Sullivan T, Leano R, Hukins C, Jenkins C, Marwick TH. Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol. 2006; 47:611–616.
crossref
12. Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013; 144:169–176.
13. Berra G, Noble S, Soccal PM, Beghetti M, Lador F. Pulmonary hypertension in the elderly: a different disease? Breathe (Sheff). 2016; 12:43–49.
crossref
14. Konstantinides SV, Torbicki A, Agnelli G, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC), et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014; 35:3033–3073. 3069a–3069k.
TOOLS
Similar articles